Intricon to Announce 2020 Fourth Quarter and Full Year Results on Thursday, February 25, 2021
Intricon Corporation (NASDAQ: IIN) announced its intent to release the 2020 fourth quarter and full year results on February 25, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Intricon Corporation (NASDAQ: IIN) announced its intent to release the 2020 fourth quarter and full year results on February 25, 2021, after market close. The management team will hold a conference call at 4:00 p.m. CT/5:00 p.m. ET on the same day, accessible via a designated call-in number. A live webcast will also be available on Intricon's website. As a Joint Development Manufacturer, Intricon focuses on enhancing micro-medical technology, partnering closely with customers throughout the development process to improve clinical outcomes.
Details
News Market Reaction – IIN
The recorded move for IIN in the trading session of this news was +1.68%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ARDEN HILLS, Minn., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering and manufacturing miniature interventional, implantable and body-worn medical devices, today announced that it will release its 2020 fourth quarter and full year results on Thursday, February 25, 2021, after market close.
Following the release, Intricon’s management team will host a conference call on the same day, beginning at 4:00 p.m. CT/5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (866) 795-7248 for domestic callers or (470) 495-9160 for international callers, using conference ID: 5468087. A live and archived webcast will be available on the “Investors” sections of the company’s website at: www.intricon.com.
About Intricon Corporation
Intricon is a Joint Development Manufacturer that integrates components and assemblies to advance micro-medical technology across a range of device platforms for global customers. Intricon approaches each engagement with an all-in commitment, working with customers every step of the way- from the earliest idea stages to ongoing production - in order to advance program performance and deliver results. With a focus on key device platforms, Intricon helps advance clinical outcomes by always looking ahead with proactive support and resources through integration of its core competencies. Intricon has facilities in the United States, Asia and Europe. The company's common stock trades under the symbol "IIN" on the NASDAQ Global Market.
Investor Relations Contact:
Leigh Salvo
(415) 937-5404
investorrelations@intricon.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.